#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Deafness neurosensory Congenital nephrogenic diabetes insipidus Myasthenia gravis Angiosarcoma metastatic Cerebral amyloid angiopathy Hepatic angiosarcoma Small cell lung cancer limited stage Parkinson's disease Thromboangiitis obliterans Diffuse large B-cell lymphoma recurrent Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Asthma Glomerulonephritis minimal lesion Anti-glomerular basement membrane disease Bronchopulmonary aspergillosis More trials…

    Learn about Rare Diseases

    Biotinidase deficiency – Basic Information Shprintzen-Goldberg syndrome – Diagnostics Advanced systemic mastocytosis – Life with Disease Atypical teratoid/rhabdoid tumour of CNS – Life with Disease Short-bowel syndrome – Basic Information Congenital nephrogenic diabetes insipidus – Treatment Splenic marginal zone lymphoma – Life with Disease Leiomyosarcoma metastatic – Treatment Testicular leiomyosarcoma – Life with Disease Nodal marginal zone B-cell lymphoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Darovasertib Cefotaxime Sodium Emicizumab Vorasidenib Iph6501 Midazolam Vincristine Ursodoxicoltaurine Macitentan Lumateperone Ergocalciferol Insulin Human Secale Cereale Vibosameran PHENTOLAMINE MESILATE Mk-1084 Treprostinil Palmitil Basiliximab Levoleucovorin DESMOPRESSIN ACETATE More therapies…

    Learn about Your Condition

    Death neonatal Catatonia Spermatocele Cervix carcinoma stage III Supraventricular tachycardia Dent's disease Lymphocyte adoptive therapy Herpes simplex Prostate cancer Breast cancer male Dermatitis Electronic cigarette user Thyroidectomy Prostate cancer recurrent Eczema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on Caplacizumab and Immunosuppressive Therapy for Adults with Immune-Mediated Thrombotic Thrombocytopenic Purpura

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Thrombotic thrombocytopenic purpura
    Investigated Drugs:
    • Caplacizumab
    Austria Belgium Czechia France Germany Greece +3

  • Study of ianalumab versus placebo in adults with warm autoimmune hemolytic anemia who failed previous treatment

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Danazol
    • Entecavir
    • Ianalumab
    France Germany Hungary Italy Romania Spain

  • Study Comparing Romiplostim and Dexamethasone with Dexamethasone Alone for Patients with Newly Diagnosed Primary Immune Thrombocytopenia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Dexamethasone Phosphate
    • Romiplostim
    Italy Spain

  • Study on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Apixaban
    • Betamethasone Sodium Phosphate
    • Cyclophosphamide Monohydrate
    Austria Bulgaria Czechia Denmark Finland France +11

  • Study on the Effects of Etavopivat for Patients Aged 12-65 with Sickle Cell Disease

    Not recruiting

    4 1
    Investigated Diseases:
    • Sickle cell disease
    Investigated Drugs:
    • Etavopivat
    France Germany Greece Italy Spain

  • Study of Elranatamab for Treating Relapsed or Refractory Multiple Myeloma in Patients Previously Treated with Three Drug Classes

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Elranatamab
    Spain
Previous Page
1 … 75 76 77 78 79 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!